| 000 | 01917 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516210209.0 | ||
| 264 | 0 | _c20140918 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-014-2465-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzijli, Kaamar | |
| 245 | 0 | 0 |
_aThe novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cJun 2014 |
||
| 300 |
_a1273-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntimetabolites _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
| 650 | 0 | 4 |
_aTNF-Related Apoptosis-Inducing Ligand _xadministration & dosage |
| 650 | 0 | 4 |
_aThymidylate Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTrifluridine _xadministration & dosage |
| 700 | 1 | _avan Roosmalen, Ingrid A M | |
| 700 | 1 | _aSmit, Jorn | |
| 700 | 1 | _aPillai, Saravanan | |
| 700 | 1 | _aFukushima, Masakazu | |
| 700 | 1 | _ade Jong, Steven | |
| 700 | 1 | _aPeters, Godefridus J | |
| 700 | 1 | _aBijnsdorp, Irene V | |
| 700 | 1 | _aKruyt, Frank A E | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 73 _gno. 6 _gp. 1273-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-014-2465-1 _zAvailable from publisher's website |
| 999 |
_c23748279 _d23748279 |
||